Taiwan FDA registration 532c7c29bb287f5fcc5d9fbd20fb10e7
Abbott "Marisi" human immunodeficiency virus antibody test reagent
TW: 亞培”妙芮絲”人類免疫缺乏病毒抗體檢驗試劑
Taiwan·Risk Class 3·DIASORIN S.P.A. UK BRANCH·Registered Aug 08, 2005 – Aug 08, 2027ActiveRegistration details
- Analysis ID
- 532c7c29bb287f5fcc5d9fbd20fb10e7
- Customs Code
- DHA00601173801
Company information
- Manufacturer
- DIASORIN S.P.A. UK BRANCH
- Manufacturer Country
- United Kingdom
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- Enzyme immunoassay for statutory testing of human immunodeficiency virus type 1 and type 2 antibodies in human serum or plasma for screening.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- import
Dates and status
- Registration Date
- Aug 08, 2005
- Expiry Date
- Aug 08, 2027
About this record
Access comprehensive regulatory information for Abbott "Marisi" human immunodeficiency virus antibody test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 532c7c29bb287f5fcc5d9fbd20fb10e7 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices